Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FSGAX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,165
Award facts
- Contract value 100% obligated
- $16,165.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a contract value of $16,165.37. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio focused on supplying medications and medical supplies to military and veteran healthcare systems. The parent IDC enables the company to deliver a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for ondansetron, an antiemetic medication commonly used in medical settings, represents a routine fulfillment under the broader pharmaceutical supply agreement supporting federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FSGAX?
SPE2DB25FSGAX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FSGAX worth?
The government has obligated $16,165 on SPE2DB25FSGAX.
Is contract SPE2DB25FSGAX an order under another contract?
Yes. SPE2DB25FSGAX is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGAX competed?
The extent of competition for SPE2DB25FSGAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award